Cancer risk in patients with osteoporosis: a population-based cohort study

References

• Chronic rheumatic conditions. World Health Organization. Available at: http://www.who.int/chp/topics/rheumatic/en/ [Last accessed 19 October 2016]
   Google Scholar
• Yang NP, Deng CY, Chou YJ, et al. Estimated prevalence of osteoporosis from a Nationwide Health Insurance database in Taiwan. Health Policy 2006;75:329-37
   PubMed Web of Science ®Google Scholar
• Ji J, Sundquist K, Sundquist J. Cancer risk after hospitalization for osteoporosis in Sweden. Eur J Cancer Prev 2012;21:395-9
   PubMed Web of Science ®Google Scholar
• McGlynn KA, Gridley G, Mellemkjaer L, et al. Risks of cancer among a cohort of 23,935 men and women with osteoporosis. Int J Cancer 2008;122:1879-84
   PubMed Web of Science ®Google Scholar
• Cauley JA, Lucas FL, Kuller LH, et al. Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group. JAMA 1996;276:1404-8
   PubMed Web of Science ®Google Scholar
• van der Klift M, de Laet CE, Coebergh JW, et al.; Rotterdam Study. Bone mineral density and the risk of breast cancer: the Rotterdam Study. Bone 2003;32:211-16
   PubMed Web of Science ®Google Scholar
• Persson I, Adami HO, McLaughlin JK, et al. Reduced risk of breast and endometrial cancer among women with hip fractures (Sweden). Cancer Causes Control 1994;5:523-8
   PubMed Web of Science ®Google Scholar
• Farhat GN, Taioli E, Cauley JA, et al. The association of bone mineral density with prostate cancer risk in the Osteoporotic Fractures in Men (MrOS) Study. Cancer Epidemiol Biomarkers Prev 2009;18:148-54
   PubMed Web of Science ®Google Scholar
• Bunker CH, Zmuda JM, Patrick AL, et al. High bone density is associated with prostate cancer in older Afro-Caribbean men: Tobago prostate survey. Cancer Causes Control 2006;17:1083-9
   PubMed Web of Science ®Google Scholar
• Zhang Y, Kiel DP, Ellison RC, et al. Bone mass and the risk of prostate cancer: the Framingham Study. Am J Med 2002;113:734-9
   PubMed Web of Science ®Google Scholar
• Lee WY, Sun LM, Lin MC, et al. A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study. PLoS One 2012;7:e53032
   PubMed Web of Science ®Google Scholar
• Sun LM, Lin MC, Muo CH, et al. Calcitonin nasal spray and increased cancer risk: a population-based nested case–control study. J Clin Endocrinol Metab 2014;99:4259-64
   PubMed Web of Science ®Google Scholar
• National Health Research Institute. National Health Insurance Research Database, Taiwan. Available at: http://nhird.nhri.org.tw/en/index.html [Last accessed 19 October 2016]
   Google Scholar
• Cancer Statistics Annual Report. Taiwan Cancer Registry. Available at: http://tcr.cph.ntu.edu.tw/main.php?Page=N2 [Last accessed 19 October 2016]
   Google Scholar
• Orwoll ES, Klein RF. Osteoporosis in men. Endocr Rev 1995;16:87-116
   PubMed Web of Science ®Google Scholar
• Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol 2006;194:S3-S11
   PubMed Web of Science ®Google Scholar
• Secretan B, Straif K, Baan R, et al. A review of human carcinogens – part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 2009;10:1033-4
   PubMed Web of Science ®Google Scholar
• Le Marchand L, Wilkens LR, Kolonel LN, et al. Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. Cancer Res 1997;57:4787-94
   PubMed Web of Science ®Google Scholar
• McTiernan A. Behavioral risk factors in breast cancer: can risk be modified? Oncologist 2003;8:326-34
   PubMed Web of Science ®Google Scholar
• Campbell KL, McTiernan A. Exercise and biomarkers for cancer prevention studies. J Nutr 2007;137:161S-9S
   PubMed Web of Science ®Google Scholar
• Shen YC, Chang CJ, Hsu C, et al. Significant difference in the trends of female breast cancer incidence between Taiwanese and Caucasian Americans: implications from age-period-cohort analysis. Cancer Epidemiol Biomarkers Prev 2005;14:1986-90
   PubMed Web of Science ®Google Scholar
• Surveillance, Epidemiology, and End Results (SEER) Program public-use data (1973–2012). Bethesda, MD: Cancer Statistics Branch, Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, 2016. Available at: http://seer.cancer.gov/statfacts/html/breast.html [Last accessed 19 October 2016]
   Google Scholar
• Gruntmanis U. Male osteoporosis: deadly, but ignored. Am J Med Sci 2007;333:85-92
   PubMed Web of Science ®Google Scholar
• Kuper H, Ye W, Broomé U, et al. The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis. Hepatology 2001;34:714-18
   PubMed Web of Science ®Google Scholar
• Sun LM, Lin, MC, Lin CL, et al. Nonalcoholic cirrhosis increased risk of digestive tract malignancies: a population-based cohort study. Medicine (Baltimore) 2015;94:e2080
   PubMed Web of Science ®Google Scholar
• Burman KD. Thyroid disease and osteoporosis. Hosp Pract (1995) 1997;32:71-3, 78-85, discussion 85-6
   PubMed Web of Science ®Google Scholar
• Lakatos P. Thyroid hormones: beneficial or deleterious for bone? Calcif Tissue Int 2003;73:205-9
   PubMed Web of Science ®Google Scholar
• Pearce EN. Thyroid dysfunction in perimenopausal and postmenopausal women. Menopause Int 2007;13:8-13
   PubMedGoogle Scholar
• Boelaert K, Franklyn JA. Thyroid hormone in health and disease. J Endocrinol 2005;187:1-15
   PubMed Web of Science ®Google Scholar
• Franks AL, Slansky JE. Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer. Anticancer Res 2012;32:1119-36
   PubMed Web of Science ®Google Scholar
• Shu X, Ji J, Li X, et al. Cancer risk in patients hospitalised for Graves’ disease: a population-based cohort study in Sweden. Br J Cancer 2010;102:1397-9
   PubMed Web of Science ®Google Scholar
• Majima T, Komatsu Y, Doi K, et al. Anaplastic thyroid carcinoma associated with Graves’ disease. Endocr J 2005;52:551-7
   PubMed Web of Science ®Google Scholar
• Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997;84:223-43
   PubMedGoogle Scholar
• Cooper DS. Hyperthyroidism. Lancet 2003;362:459-68
   PubMed Web of Science ®Google Scholar
• Chen YK, Lin CL, Chang YJ, et al. Cancer risk in patients with Graves’ disease: a nationwide cohort study. Thyroid 2013;23:879-84
   PubMed Web of Science ®Google Scholar
• Hercbergs AH, Ashur-Fabian O, Garfield D. Thyroid hormones and cancer: clinical studies of hypothyroidism in oncology. Curr Opin Endocrinol Diabetes Obes 2010;17:432-6
   PubMed Web of Science ®Google Scholar
• Pazaitou-Panayiotou K, Michalakis K, Paschke R. Thyroid cancer in patients with hyperthyroidism. Horm Metab Res 2012;44:255-62
   PubMed Web of Science ®Google Scholar
• Lim JU, Cha JM, Lee JI, et al. Osteoporosis is associated with the risk of colorectal adenoma in women. Dis Colon Rectum 2013;56:169-74
   PubMed Web of Science ®Google Scholar
• Nelson RL, Turyk M, Kim J, Persky V. Bone mineral density and the subsequent risk of cancer in the NHANES I follow-up cohort. BMC Cancer 2002;2:22
   PubMed Web of Science ®Google Scholar
• Thosani N, Thosani SN, Kumar S, et al. Reduced risk of colorectal cancer with use of oral bisphosphonates: a systematic review and meta-analysis. J Clin Oncol 2013;31:623-30
   PubMed Web of Science ®Google Scholar
• Osteoporosis drug may reduce colon cancer risk. Mayo Clin Health Lett 2011;29:4
   Google Scholar
• Heine-Bröring RC, Winkels RM, Renkema JM, et al. Dietary supplement use and colorectal cancer risk: a systematic review and meta-analyses of prospective cohort studies. Int J Cancer 2015;136:2388-401
   PubMed Web of Science ®Google Scholar
• Wroński K, Bocian R. The patient’s knowledge about the role of calcium in the primary prevention of colorectal cancer. Contemp Oncol (Pozn) 2012;16:440-3
   PubMed Web of Science ®Google Scholar
• Klampfer L. Vitamin D and colon cancer. World J Gastrointest Oncol 2014;6:430-7
   PubMed Web of Science ®Google Scholar
• Meads MB, Hazlehurst LA, Dalton WS. The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance. Clin Cancer Res 2008;14:2519-26
   PubMed Web of Science ®Google Scholar
• Sun YX, Schneider A, Jung Y, et al. Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo. J Bone Miner Res 2005;20:318-29
   PubMed Web of Science ®Google Scholar
• Li D, Qian W, Li RR, et al. Correlation between lung neoplasm and serum level of osteopontin: a meta-analysis. Biomed Rep 2016;4:567-72
   PubMed Web of Science ®Google Scholar
• Yang G, Peng X, Guo P, Yang G. Association of osteopontin polymorphism with cancer risk: a meta-analysis. Int J Clin Exp Med 2015;8:20911-17
   PubMed Web of Science ®Google Scholar